Scarica l'app Stockscreener
34.40
1.99%
-0.70
Dopo l'orario di chiusura:
34.40
Precedente Chiudi:
$35.10
Aprire:
$35.58
Volume 24 ore:
1.04M
Relative Volume:
1.53
Capitalizzazione di mercato:
$1.56B
Reddito:
$1.18B
Utile/perdita netta:
$2.05M
Rapporto P/E:
796.30
EPS:
0.0432
Flusso di cassa netto:
$66.94M
1 W Prestazione:
-16.71%
1M Prestazione:
-5.75%
6M Prestazione:
+8.07%
1 anno Prestazione:
+6.57%
Intervallo 1D:
$33.87
$35.62
Intervallo di 1 settimana:
$33.87
$40.71
Portata 52W:
$22.66
$55.00
Omnicell Inc Stock (OMCL) Company Profile
Nome
Omnicell Inc
Settore
Industria
Telefono
(877) 415-9990
Indirizzo
4220 NORTH FREEWAY, FORT WORTH
Compare OMCL vs VEEV, TEM, BTSG, HQY, WAY
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
OMCL
Omnicell Inc
|
34.40 | 1.56B | 1.18B | 2.05M | 66.94M | 0.0432 |
|
VEEV
Veeva Systems Inc
|
178.88 | 29.40B | 3.20B | 908.91M | 1.42B | 5.4155 |
|
TEM
Tempus Ai Inc
|
49.98 | 8.94B | 1.27B | -245.03M | -245.36M | -1.4071 |
|
BTSG
Brightspring Health Services Inc
|
38.31 | 7.36B | 12.91B | 104.80M | 394.69M | 0.8769 |
|
HQY
Healthequity Inc
|
77.81 | 6.65B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
24.16 | 4.63B | 1.10B | 112.09M | 283.19M | 0.6096 |
Omnicell Inc Stock (OMCL) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-02-04 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2026-01-08 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2025-05-14 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2024-10-31 | Downgrade | BofA Securities | Buy → Neutral |
| 2024-08-02 | Aggiornamento | Barclays | Underweight → Equal Weight |
| 2024-01-03 | Iniziato | Barclays | Underweight |
| 2023-11-03 | Downgrade | BTIG Research | Buy → Neutral |
| 2023-11-03 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2023-11-03 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
| 2023-10-11 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-09-26 | Reiterato | Wells Fargo | Underweight |
| 2023-08-02 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2023-07-20 | Downgrade | Wells Fargo | Overweight → Underweight |
| 2023-02-27 | Aggiornamento | The Benchmark Company | Hold → Buy |
| 2022-11-03 | Downgrade | The Benchmark Company | Buy → Hold |
| 2022-09-16 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2022-09-09 | Iniziato | BofA Securities | Buy |
| 2022-07-15 | Iniziato | SVB Leerink | Mkt Perform |
| 2021-12-06 | Ripresa | Wells Fargo | Overweight |
| 2021-06-09 | Iniziato | JP Morgan | Neutral |
| 2021-05-24 | Iniziato | BTIG Research | Buy |
| 2021-02-02 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2020-12-08 | Iniziato | Berenberg | Buy |
| 2020-12-03 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2020-07-07 | Iniziato | Stephens | Overweight |
| 2020-02-07 | Reiterato | Dougherty & Company | Buy |
| 2019-11-21 | Reiterato | Dougherty & Company | Buy |
| 2019-07-26 | Aggiornamento | Craig Hallum | Hold → Buy |
| 2019-03-07 | Reiterato | Dougherty & Company | Buy |
| 2018-06-29 | Ripresa | The Benchmark Company | Buy |
| 2017-09-05 | Reiterato | The Benchmark Company | Buy |
| 2017-07-28 | Reiterato | Dougherty & Company | Buy |
| 2017-04-21 | Downgrade | Piper Jaffray | Overweight → Neutral |
| 2017-01-19 | Iniziato | Dougherty & Company | Buy |
| 2016-12-06 | Reiterato | The Benchmark Company | Buy |
| 2016-07-07 | Reiterato | FBR Capital | Outperform |
| 2016-03-21 | Reiterato | Topeka Capital Markets | Buy |
| 2016-01-07 | Iniziato | The Benchmark Company | Buy |
| 2015-11-16 | Reiterato | Topeka Capital Markets | Buy |
| 2015-10-30 | Reiterato | FBR Capital | Outperform |
| 2015-09-28 | Aggiornamento | Sidoti | Neutral → Buy |
| 2015-07-31 | Reiterato | Topeka Capital Markets | Buy |
Mostra tutto
Omnicell Inc Borsa (OMCL) Ultime notizie
Benchmark reiterates Omnicell stock rating on product cycle outlook - Investing.com Australia
Omnicell (NASDAQ:OMCL) Rating Increased to Hold at Zacks Research - MarketBeat
Telepharmacy Market Set to Witness Rapid Growth Through 2033 | - openPR.com
Omnicell (OMCL) to Participate in Benchmark's Virtual Meeting on March 11 - GuruFocus
How Omnicell Inc. (OMCL) Affects Rotational Strategy Timing - Stock Traders Daily
What is Zacks Research's Estimate for Omnicell Q2 Earnings? - MarketBeat
Omnicell (OMCL) Analyst Maintains 'Buy' Rating, Raises Price Tar - GuruFocus
Quantbot Technologies LP Purchases Shares of 25,813 Omnicell, Inc. $OMCL - MarketBeat
Pharmacy Repackaging Systems Market Is Going to Boom Rapidly | - openPR.com
Intech Investment Management LLC Sells 135,679 Shares of Omnicell, Inc. $OMCL - MarketBeat
Omnicell Leans Into Healthcare IT As ANiGENT Deal Reshapes Growth Story - Sahm
Aug Patterns: Is Omnicell Inc a play on infrastructure spendingGold Moves & High Conviction Investment Ideas - baoquankhu1.vn
How The Titan XT Cycle Is Rewriting The Omnicell (OMCL) Investment Story - Yahoo Finance
Will Strong Q4 Beat and Software Pivot Change Omnicell's (OMCL) Investment Narrative? - Yahoo Finance
JPMorgan Chase & Co. Sells Omnicell, Inc. $OMCL Shares - National Today
Omnicell, Inc. $OMCL Shares Sold by JPMorgan Chase & Co. - MarketBeat
Omnicell Stock Analysis: Strong Performance vs. Long-Term ConcernsNews and Statistics - IndexBox
OMCL Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Omnicell, Inc. (OMCL) Stock Analysis: Strong Buy Ratings And Nearly 40% Upside Potential - DirectorsTalk Interviews
3 Reasons to Avoid OMCL and 1 Stock to Buy Instead - Yahoo Finance
Vanguard Group Inc. Has $170.89 Million Holdings in Omnicell, Inc. $OMCL - MarketBeat
Roubaix Capital LLC Purchases Shares of 76,383 Omnicell, Inc. $OMCL - MarketBeat
Assessing Omnicell (OMCL) Valuation As ANiGENT Deal Accelerates Shift To Software And Services - simplywall.st
What is Zacks Research's Estimate for Omnicell Q1 Earnings? - MarketBeat
Dividend Watch: Whats the fair value of Omnicell Inc stockEarnings Overview Summary & Verified Momentum Stock Watchlist - baoquankhu1.vn
Should Omnicell’s Shift Toward Software and Services Require Action From Omnicell (OMCL) Investors? - simplywall.st
Omnicell, Inc. (OMCL): A Bull Case Theory - Finviz
OMCL Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
What is Zacks Research's Estimate for Omnicell Q3 Earnings? - MarketBeat
Omnicell, Inc. (NASDAQ:OMCL) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Decoding Omnicell Inc (OMCL): A Strategic SWOT Insight - GuruFocus
(OMCL) and the Role of Price-Sensitive Allocations - Stock Traders Daily
Omnicell, Inc. (OMCL) Investor Outlook: Examining a 45% Potential Upside Amid Healthcare Innovation - DirectorsTalk Interviews
Guardant Health, PacBio, Align Technology, QuidelOrtho, and Omnicell Shares Are Falling, What You Need To Know - Finviz
Healthcare Inventory Management Market Hits New High | Major - openPR.com
Omnicell Inc (OMCL) Trading 3.26% Higher on Feb 20 - GuruFocus
Omnicell (OMCL) COO has 1,146 shares withheld for RSU taxes - Stock Titan
Omnicell (OMCL) insider plans Rule 144 sale of 4,243 vested shares - Stock Titan
Hospital Robotics (Logistics and Pharmacy) Market to Reach USD - openPR.com
Does Omnicell’s Profit Squeeze Amid Higher Sales and 2026 Outlook Change The Bull Case For OMCL? - simplywall.st
Merger Talk: Is NewAmsterdam Pharma Company NVs ROIC above industry average2025 Technical Overview & Fast Exit and Entry Strategy Plans - baoquankhu1.vn
Omnicell, Inc. (NASDAQ:OMCL) Sees Large Drop in Short Interest - MarketBeat
Responsive Playbooks and the OMCL Inflection - Stock Traders Daily
Growth Report: How volatile is Omnicell Inc stock2025 Price Momentum & AI Powered Buy/Sell Recommendations - baoquankhu1.vn
Reasons to add Omnicell stock to your portfolio right now - MSN
Smart Medicine Compounding Robot Market Is Going to Boom | ARxIUM - openPR.com
Reassessing Omnicell (OMCL) After Sharp Multi‑Year Share Price Declines - simplywall.st
Omnicell (OMCL) Is Down 19.0% After Profit Squeeze Despite Solid 2026 Revenue OutlookWhat's Changed - Yahoo Finance
Little Excitement Around Omnicell, Inc.'s (NASDAQ:OMCL) Revenues As Shares Take 26% Pounding - 富途牛牛
Why Investors Shouldn't Be Surprised By Omnicell, Inc.'s (NASDAQ:OMCL) 26% Share Price Plunge - simplywall.st
The Top 5 Analyst Questions From Omnicell's Q4 Earnings Call - Finviz
Omnicell Inc Azioni (OMCL) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.79%
1.21%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):